REQUEST A DEMO
Total
USD $0.00
Search more companies

Pronuclear S A S (Colombia)

Main Activities: Pharmacies and Drug Stores
Full name: Pronuclear S A S Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Pronuclear S A S is based in Colombia, with the head office in Bogota D.C.. The enterprise operates in the Pharmacies and Drug Stores industry. It was incorporated on July 24, 2001. Pronuclear S A S currently employs 8 (2024) people. In its most recent financial highlights, the company reported a net sales revenue increase of 76.42% in 2023. Its total assets grew by 1.65% over the same period. The net profit margin of Pronuclear S A S increased by 8% in 2023.

Headquarters
Cra 18 N 166-32
Bogota D.C.; Bogota D.C;

Contact Details: Purchase the Pronuclear S A S report to view the information.

Basic Information
Total Employees:
Purchase the Pronuclear S A S report to view the information.
Outstanding Shares:
Purchase the Pronuclear S A S report to view the information.
Incorporation Date:
July 24, 2001
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Pronuclear S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
76.42%
Total operating revenue
76.42%
Operating profit (EBIT)
6138.95%
Net Profit (Loss) for the Period
2333.06%
Total assets
1.65%
Total equity
120.13%
Operating Profit Margin (ROS)
13.56%
Net Profit Margin
8%
Return on Equity (ROE)
5.74%
Quick Ratio
6.62%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?